These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

53 related items for PubMed ID: 7565583

  • 1. [Wild type p53 tumor suppressor gene and apoptosis in thyroid tumors: preliminary report].
    Kikuchi S, Hiraide H, Tamakuma S, Yamamoto M.
    Nihon Geka Gakkai Zasshi; 1995 Aug; 96(8):588. PubMed ID: 7565583
    [No Abstract] [Full Text] [Related]

  • 2. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K, Dedivitis RA, Kapitanović S, Cacev T, Guirado CR, Danić D, Radosević S, Brkić K, Pegan B, Krizanac S, Kusić Z, Spaventi S, Bura M.
    Mutat Res; 2006 Jul 25; 599(1-2):45-57. PubMed ID: 16698048
    [Abstract] [Full Text] [Related]

  • 3. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G, Antonaci A, Bosco D, Nardoni S, Melis M.
    J Exp Clin Cancer Res; 1999 Sep 25; 18(3):363-7. PubMed ID: 10606183
    [Abstract] [Full Text] [Related]

  • 4. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
    Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G, Pierotti MA.
    J Clin Invest; 1993 Apr 25; 91(4):1753-60. PubMed ID: 8473515
    [Abstract] [Full Text] [Related]

  • 5. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR.
    Head Neck; 2004 Oct 25; 26(10):870-7. PubMed ID: 15390206
    [Abstract] [Full Text] [Related]

  • 6. [Antioncogene p53 and apoptosis response: new hypotheses on the molecular bases of tumor resistance to radiotherapy].
    Corvò R.
    Radiol Med; 1996 Sep 25; 92(3):298-302. PubMed ID: 8975319
    [Abstract] [Full Text] [Related]

  • 7. Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours.
    Wright PA, Lemoine NR, Goretzki PE, Wyllie FS, Bond J, Hughes C, Röher HD, Williams ED, Wynford-Thomas D.
    Oncogene; 1991 Sep 25; 6(9):1693-7. PubMed ID: 1923534
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.
    Moretti F, Farsetti A, Soddu S, Misiti S, Crescenzi M, Filetti S, Andreoli M, Sacchi A, Pontecorvi A.
    Oncogene; 1997 Feb 13; 14(6):729-40. PubMed ID: 9038381
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of wild-type p53 tumor suppressor gene and its possible involvement in the apoptosis of thyroid tumors.
    Kikuchi S, Hiraide H, Tamakuma S, Yamamoto M.
    Surg Today; 1997 Feb 13; 27(3):226-33. PubMed ID: 9068103
    [Abstract] [Full Text] [Related]

  • 16. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL.
    Cancer Gene Ther; 2000 Nov 13; 7(11):1469-80. PubMed ID: 11129289
    [Abstract] [Full Text] [Related]

  • 17. Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations.
    Shahedian B, Shi Y, Zou M, Farid NR.
    Mol Genet Metab; 2001 Feb 13; 72(2):155-63. PubMed ID: 11161841
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma.
    Sápi Z, Lukács G, Sztán M, Papp J, Oláh E.
    Diagn Mol Pathol; 1995 Dec 13; 4(4):256-60. PubMed ID: 8634781
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.